Pharmacy Is Right For Me

OCTOBER 15, 2024

Hello everyone, my name is Diana Martinez-Nava and I am a fourth-year student pharmacist at The University of New Mexico College of Pharmacy. I would like to take some time on this special month celebrating our Hispanic Heritage to share my story on my pharmacy journey. My interest in becoming a pharmacist began around the time I was 8 years old. I was that small child who could barely see over the counter at our neighborhood pharmacy next to my father’s arm who would be reaching out to collect,

Community Pharmacies 130

Community Pharmacies 130

Drug Topics

OCTOBER 15, 2024

The financial burden of in vitro fertilization (IVF) medications has become increasingly prohibitive, limiting the availability of fertility treatments for many.

215

215

STAT

OCTOBER 15, 2024

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up  to get it in your inbox every Monday. Hello, you spry bunch. We’re coming to you on a Tuesday after yesterday’s holiday. What are you looking to read more about as the year winds down? Let us know: bob.herman@statnews.com.

Insurance 143

Insurance 143

Drug Topics

OCTOBER 15, 2024

In a systematic review, researchers explored the role of clinical pharmacists within a multidisciplinary team treating patients with inflammatory bowel disease.

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

OCTOBER 15, 2024

It was a dramatic call to action by the American Heart Association: The organization declared its decade-long goal culminating in 2020 was to slash deaths from cardiovascular disease and stroke by 20%. It also promised in its scientific journal to move all Americans toward “ideal cardiovascular health.” That never happened. Deaths did decrease by 15% from 2010, but it was a “disappointment” that fatalities linked to conditions like high blood pressure, heart failure,

142

142

Fierce Healthcare

OCTOBER 15, 2024

Walgreens reported a loss of $3 billion in the fourth quarter and plans to close 1,200 stores over the next three years as part of the retail drugstore chain's ongoing turnaround strategy amid a ro | Walgreens reported a loss of $3 billion in the fourth quarter and plans to close 1,200 stores over the next three years as part of the retail drugstore chain's ongoing turnaround strategy amid a rocky fiscal 2024.

132

132

Fierce Healthcare

OCTOBER 15, 2024

The Drug Enforcement Administration is poised to extend pandemic-era telehealth prescribi | The third temporary extension is rumored to be for just one year, punting the deadline for the next administration to negotiate permanent rules to December 2025. Telemedicine companies, including those that prescribe Adderall, will be able to continue prescribing as they have since 2020.

131

131

STAT

OCTOBER 15, 2024

On Sept. 26, the FDA approved the first truly new antipsychotic in decades: Cobenfy. In clinical trials, it didn’t cause certain side effects that traditionally interfere with medication adherence, including weight gain, lethargy, and movement disorders. I have schizoaffective disorder, bipolar type — a combination of schizophrenia and bipolar disorder — and I agree that this is a monumental development for my community.

FDA 141

FDA 141

Pharmacy Times

OCTOBER 15, 2024

Shirish Gadgeel, MD, discusses an integrated analysis of the regional TRUST-I study and global TRUST-II study presented at the European Society for Medical Oncology Congress 2024.

120

120

Drug Topics

OCTOBER 15, 2024

David Pope, PharmD, Chief Pharmacy Officer at XiPhin, shared his thoughts on value-based care and how it is used within a pharmacy setting.

123

123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

OCTOBER 15, 2024

Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK is targeting Moderna in a pair of lawsuits alleging the Massachusetts-ba | GSK is targeting Moderna in a pair of lawsuits claiming the mRNA specialist violated multiple patents with its vaccines Spikevax and mRESVIA. In the complaints, GSK says it hopes to recover a “reasonable royalty” tied to Moderna’s vaccine sales, plus damages.

Vaccines 122

Vaccines 122

STAT

OCTOBER 15, 2024

Hello, everyone, and how are you today? We are doing just fine, thank you, especially after a lengthy weekend respite. Of course, we have returned to the usual routines, so we are firing up the trusty coffee kettle as we brace for another round of deadlines, online meetings, and the like. No doubt, you may relate. So please join us as we hoist our cup of stimulation — our choice today is cinnamon vanilla — and get cracking.

111

111

Drug Topics

OCTOBER 15, 2024

Pharmacists can screen for social determinants of health and patient beliefs about medications as a way to improve adherence and subsequent outcomes in heart failure.

101

101

STAT

OCTOBER 15, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Why nurses liked an AI bot more than doctors did An interesting research letter out in JAMA Network Open suggests attitudes toward large language models in health care could vary based on license and professional role.

110

110

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

OCTOBER 15, 2024

Imuldosa has received approval for all indications of its reference product, including ulcerative colitis, psoriatic arthritis, and Crohn disease.

FDA 110

FDA 110

pharmaphorum

OCTOBER 15, 2024

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster.The Danish drugmaker has offered $60 per share for California biotech Longboard, with the main asset in the deal bexicaserin, an oral, centrally acting serotonin 5-HT 2C receptor super-agonist in late-stage testing for seizures associated with rare forms of epilepsy.

104

104

PharmaVoice

OCTOBER 15, 2024

A Nobel Prize in chemistry for Google’s DeepMind protein-structure mapping is the tip of the iceberg for advances in drug discovery and development.

111

111

Fierce Healthcare

OCTOBER 15, 2024

UnitedHealth Group kicked off another round of earnings calls for major health insurance companies Tuesday morning, when it

Health Insurance Companies 122

Health Insurance Companies Insurance 122

Drug Topics

OCTOBER 15, 2024

The first-line B/F/TAF regiment was evaluated in Hispanic/Latino patients, as well as in those with chronic kidney disease.

98

98

STAT

OCTOBER 15, 2024

It’s the most wonderful time of the year — STAT Summit week! I love when my colleagues come into town, and not only because it means we’re more likely to get free lunch at the office. (Today? I heard pizza!)  There are a lot of great conversations ahead. It’s not too late for you to join us , in person or virtually! Why aren’t we doing better in the battle against cardiovascular disease?

97

97

Pharmacy Times

OCTOBER 15, 2024

Investigators state that health care providers should consider the potential use of 2 doses to increase the effectiveness against influenza B.

Vaccines 102

Vaccines 102

STAT

OCTOBER 15, 2024

Hello! Hope you had a restful and reflective Indigenous Peoples’ Day. Today, we talk about how the autoimmune disease space is hotter than ever, see more gene therapy contraction, and the CEO of a generics giant talks about how elections affect industry. The need-to-know this morning Johnson & Johnson reported third-quarter earnings. Investment in autoimmune disease is soaring Investment has surged this year in autoimmune disease: More than $1.7 billion has been committed to this spac

96

96

Fierce Pharma

OCTOBER 15, 2024

Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it could prolong patients’ lives in extensive-stage small cell lung cancer (ES- | Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it could prolong patients’ lives in extensive-stage small cell lung cancer.

97

97

pharmaphorum

OCTOBER 15, 2024

GSK has filed lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and RSV

Vaccines 116

Vaccines 116

STAT

OCTOBER 15, 2024

Why aren’t we doing better in the battle against cardiovascular disease?  Over the last few months, STAT put that question to nearly a dozen experts in cardiology, primary care, endocrinology, and vascular disease. Nearly all of them, as a related article details, pointed to a crisis in primary care.

118

118

Fierce Healthcare

OCTOBER 15, 2024

Blue Cross Blue Shield plans have agreed to a $2.8 billion settlement to resolve legal allegations from a slew of providers who claim the insurers colluded to prevent competition and lower reimburs | Blue Cross Blue Shield plans have agreed to a $2.8 billion settlement to resolve legal allegations from a slew of providers who claim the insurers colluded to prevent competition and lower reimbursements.

Insurance 90

Insurance 90

Pharmacy Times

OCTOBER 15, 2024

Legislative efforts in the states and Washington, DC, have made progress, but there is still a way to go.

111

111

pharmaphorum

OCTOBER 15, 2024

Health plans, employers, and healthcare providers plan to increase their spending on digital health technologies in the next 12 months, says PHTI survey

101

101

Pharmacy Times

OCTOBER 15, 2024

Two MUSC pharmacy technicians discuss how techs are pivotal in pharmacy, whether in the community or clinical setting, and how it is important to maintain high standard of care in a changing environment.

87

87

Pharmaceutical Technology

OCTOBER 15, 2024

Huawei hosted GITEX's Industrial Digital and Intelligent Transformation Summit and launched joint solutions with partners for ten industries.

93

93

Pharmacy Times

OCTOBER 15, 2024

Glucocorticoids improved outcomes for patients with Kawasaki disease at high risk of IVIG resistance without glucocorticoid-related adverse effects.

120

120

The Honest Apothecary

OCTOBER 15, 2024

Social media has managed to blur the lines between work life and home life. These days many of us are growing more comfortable openly sharing things about ourselves that might not normally be public knowledge to our co-workers or our boss. With just a few clicks our pals at work can be flipping through our […] The post Creepy, Stalking Bosses appeared first on The Honest Apothecary.

80

80

STAT

OCTOBER 15, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration.  With all eyes currently on the upcoming U.S. elections, it’s easy to forget that this year more than 75 countries have headed to the polls or will soon.

Pharmaceutical Companies 102

Pharmaceutical Companies Pharmaceutical Companies 102

pharmaphorum

OCTOBER 15, 2024

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment.

Vaccines 98

Vaccines 98